Bone Biologics (BBLG) Receivables - Accured (2025)
Bone Biologics (BBLG) reported Receivables - Accured of $9895.0 for Q4 2025.
Bone Biologics (BBLG) Receivables - Accured (2025) Analysis & Trends
Bone Biologics (BBLG) has 1 years of Receivables - Accured data on file, last reported at $9895.0 in Q4 2025.
- Receivables - Accured for Q4 2025 came in at $9895.0, changed N/A year-over-year; the trailing twelve-month figure through Dec 2025 was $9895.0 (changed N/A YoY), and the FY2025 annual result was $9895.0, changed N/A from the prior year.
- Receivables - Accured held at $9895.0 in Q4 2025 per BBLG's latest filing.
- Over five years, Receivables - Accured peaked at $9895.0 in Q4 2025 and troughed at $9895.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables - Accured (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | - |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | - |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | - |
| 10 | Bone Biologics | 1.47 Mn | 1.47 Mn | - | 9,895.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 9,895.00 |
| Dec 31, 2025 | 9,895.00 |